Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration

Oncotarget

Volumn 7, Issue 45, 2016, Pages 72381-72394

  Permuth, Jennifer B ^a   Reid, Brett ^a   Earp, Madalene ^b   Chen, Y Ann ^a   Monteiro, Alvaro N A ^a   Chen, Zhihua ^a   Chenevix Trench, Georgia ^c   Fasching, Peter A ^e,f   Beckmann, Matthias W ^f   Lambrechts, Diether ^g,h   Vanderstichele, Adriaan ⁱ   Van Niewenhuyse, Els ⁱ   Vergote, Ignace ⁱ   Rossing, Mary Anne ^j,k   Doherty, Jennifer Anne ^l   Chang Claude, Jenny ^m,n   Moysich, Kirsten ^o   Odunsi, Kunle ^o   Goodman, Marc T ^p   Shvetsov, Yurii B ^q   Wilkens, Lynne R ^q   Thompson, Pamela J ^p   Dörk, Thilo ^r   Bogdanova, Natalia ^r   Butzow, Ralf ^s   Nevanlinna, Heli ^s   Pelttari, Liisa ^s   Leminen, Arto ^s   Modugno, Francesmary ^t,u,v   Edwards, Robert P ^t,u   Ness, Roberta B ^w   Kelley, Joseph ^t   Heitz, Florian ^x,y   Karlan, Beth ^p   Lester, Jenny ^p   Kjaer, Susanne K ^z,aa   Jensen, Allan ^z   Giles, Graham ^ab,ac,ad   Hildebrandt, Michelle ^ae   Liang, Dong ^af   Lu, Karen H ^ae   Wu, Xifeng ^ae   Levine, Douglas A ^ag   Bisogna, Maria ^ag   Berchuck, Andrew ^ah   Cramer, Daniel W ^ai,aj   Terry, Kathryn L ^ai,aj   Tworoger, Shelley S ^ai,aj   Poole, Elizabeth M ^ai   Bandera, Elisa V ^ak   Fridley, Brooke ^al   Cunningham, Julie ^b   Winham, Stacey J ^b   Olson, Sara H ^ag   Orlow, Irene ^ag   Bjorge, Line ^am,an   Kiemeney, Lambertus A ^ao   Massuger, Leon ^ap   Pejovic, Tanja ^aq,ar   Moffitt, Melissa ^aq,ar   Le, Nhu ^as   Cook, Linda S ^at   Brooks Wilson, Angela ^as,au   Kelemen, Linda E ^av   Gronwald, Jacek ^aw   Lubinski, Jan ^aw   Wentzensen, Nicolas ^ax   Brinton, Louise A ^ax   Lissowska, Jolanta ^ay   Yang, Hanna ^ax   Hogdall, Estrid ^z   Hogdall, Claus ^az   Lundvall, Lene ^az   Pharoah, Paul D P ^ba,bb   Song, Honglin ^bb   Campbell, Ian ^d,ac   Eccles, Diana ^bc   McNeish, Iain ^bd   Whittemore, Alice ^be   McGuire, Valerie ^be   Sieh, Weiva ^be   Rothstein, Joseph ^be   Phelan, Catherine M ^a   Risch, Harvey ^bf   Narod, Steven ^bg   McLaughlin, John ^bh   Anton Culver, Hoda ^bi   Ziogas, Argyrios ^bj   Menon, Usha ^bf   Gayther, Simon ^bk   Ramus, Susan J ^bk   Gentry Maharaj, Aleksandra ^bl   Pearce, Celeste Leigh ^bk,bm   Wu, Anna H ^bk   Kupryjanczyk, Jolanta ^ay   Dansonka Mieszkowska, Agnieszka ^ay   Schildkraut, Joellen M ^ah,bn   Cheng, Jin Q ^a   Goode, Ellen L ^b   Sellers, Thomas A ^a,bo   more..

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j Fred Hutchinson Cancer Research Center   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

^l DARTMOUTH MEDICAL SCHOOL   (United States)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^o ROSWELL PARK CANCER INSTITUTE   (United States)

^p CEDARS SINAI MEDICAL CENTER   (United States)

^q UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^r HANNOVER MEDICAL SCHOOL   (Germany)

^s HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^t UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^u UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^v UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^w UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^x KLINIKEN ESSEN MITTE   (Germany)

^y DR HORST SCHMIDT KLINIKEN   (Germany)

^z DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^aa UNIVERSITY OF COPENHAGEN   (Denmark)

^ab CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ac UNIVERSITY OF MELBOURNE   (Australia)

^ad MONASH UNIVERSITY   (Australia)

^ae UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^af TEXAS SOUTHERN UNIVERSITY   (United States)

^ag MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ah DUKE UNIVERSITY MEDICAL CENTER   (United States)

^ai BRIGHAM AND WOMEN S HOSPITAL   (United States)

^aj HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ak RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^al UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^am UNIVERSITY OF BERGEN   (Norway)

^an HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^ao RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^ap RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^aq OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^ar OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^as BRITISH COLUMBIA CANCER AGENCY   (Canada)

^at UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^au SIMON FRASER UNIVERSITY   (Canada)

^av MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^aw POMERANIAN MEDICAL UNIVERSITY   (Poland)

^ax NATIONAL CANCER INSTITUTE   (United States)

^ay INSTITUTE OF ONCOLOGY   (Poland)

^az Rigshospitalet   (Denmark)

^ba UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bb UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bc UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^bd UNIVERSITY OF GLASGOW   (United Kingdom)

^be STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bf YALE UNIVERSITY   (United States)

^bg UNIVERSITY OF TORONTO   (Canada)

^bh PUBLIC HEALTH ONTARIO   (Canada)

^bi UNIVERSITY OF CALIFORNIA   (United States)

^bj UNIVERSITY OF CALIFORNIA   (United States)

^bk UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^bl UNIVERSITY COLLEGE LONDON   (United Kingdom)

^bm UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^bn DUKE CANCER INSTITUTE   (United States)

^bo Ovarian Cancer Association Consortium   (United States)

more..

Author keywords

Ovarian cancer risk; Polymorphisms; RNA editing

Indexed keywords

RNA;

3' UNTRANSLATED REGION; ADAD1 GENE; ADAR GENE; ADAR2 GENE; ADAR3 GENE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EUROPEAN; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OVARY CARCINOMA; QUANTITATIVE TRAIT LOCUS; RNA EDITING; SINGLE NUCLEOTIDE POLYMORPHISM; SND1 GENE; TUMOR GENE; ANIMAL; DISEASE PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED; OVARY TUMOR;

ANIMALS; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC VARIATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA EDITING;

EID: 84995776558     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10546     Document Type: Article

References (28)

1. Dominissini D, Moshitch-Moshkovitz S, Amariglio N and Rechavi G. Adenosine-to-inosine RNA editing meets cancer. Carcinogenesis. 2011; 32(11):1569-1577.
2. Han L, Diao L, Yu S, Xu X, Li J, Zhang R, Yang Y, Werner HM, Eterovic AK, Yuan Y, Li J, Nair N, Minelli R, et al. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer cell. 2015; 28(4):515-528.
3. Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E and Levanon EY. Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors. Cell reports. 2015; 13(2):267-276.
4. Galeano F, Tomaselli S, Locatelli F and Gallo A. A-to-I RNA editing: the "ADAR" side of human cancer. Semin Cell Dev Biol. 2012; 23(3):244-250.
5. American Cancer Society. Cancer Facts and Figures 2016. Atlanta: American Cancer Society. 2016.
6. Urunsak IF, Gulec UK, Paydas S, Seydaoglu G, Guzel AB and Vardar MA. Adenosine deaminase activity in patients with ovarian neoplasms. Arch Gynecol Obstet. 2012; 286(1):155-159.
7. Pragathi P, Bharath Kumar PV, Amar Kumar P, Ramakanth Reddy M, Sravani V, Neeraja J, Reeba Mary E and Gopalakrishna K. Evaluation of serum adenosine deaminase and 5'-nucleotidase activities as probable markers in ovarian cancer. Indian journal of clinical biochemistry: IJCB. 2005; 20(2):195-197.
8. Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F, Chenevix-Trench G, Chang-Claude J, Wang-Gohrke S, Ramus S, Pharoah P and Berchuck A. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol. 2009; 3(2):171-181.
9. Aberrant RNA Editing Is a Potential Driver in Cancer. Cancer discovery. 2015; 5(12):OF12.
10. Anadon C, Guil S, Simo-Riudalbas L, Moutinho C, Setien F, Martinez-Cardus A, Moran S, Villanueva A, Calaf M, Vidal A, Lazo PA, Zondervan I, Savola S, et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene. 2015.
11. Zipeto MA, Jiang Q, Melese E and Jamieson CH. RNA rewriting, recoding, and rewiring in human disease. Trends in molecular medicine. 2015; 21(9):549-559.
12. Oguro R, Kamide K, Katsuya T, Akasaka H, Sugimoto K, Congrains A, Arai Y, Hirose N, Saitoh S, Ohishi M, Miura T and Rakugi H. A single nucleotide polymorphism of the adenosine deaminase, RNA-specific gene is associated with the serum triglyceride level, abdominal circumference, and serum adiponectin concentration. Exp Gerontol. 2012; 47(2):183-187.
13. Barry CP and Lind SE. Adenosine-mediated killing of cultured epithelial cancer cells. Cancer Res. 2000; 60(7):1887-1894.
14. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S and Freedman ML. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell. 2013; 152(3):633-641.
15. Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature communications. 2015; 6:8234.
16. Li Q, Stram A, Chen C, Kar S, Gayther S, Pharoah P, Haiman C, Stranger B, Kraft P and Freedman ML. Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types. Hum Mol Genet. 2014; 23(19):5294-5302.
17. Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, et al. GWAS metaanalysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013; 45(4):362-370.
18. Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, et al. Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011.
19. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474(7353):609-615.
20. Howie B, Fuchsberger C, Stephens M, Marchini J and Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012; 44(8):955-959.
21. Marchini J and Howie B. Genotype imputation for genomewide association studies. Nature reviews Genetics. 2010; 11(7):499-511.
22. Zheng HF, Rong JJ, Liu M, Han F, Zhang XW, Richards JB and Wang L. Performance of genotype imputation for low frequency and rare variants from the 1000 genomes. PLoS One. 2015; 10(1):e0116487.
23. Daniel C, Lagergren J and Ohman M. RNA editing of noncoding RNA and its role in gene regulation. Biochimie. 2015.
24. Sankararaman S, Sridhar S, Kimmel G and Halperin E. Estimating local ancestry in admixed populations. American journal of human genetics. 2008; 82(2):290-303.
25. Storey JD and Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100(16):9440-9445.
26. Tyrer JP, Guo Q, Easton DF and Pharoah PD. The admixture maximum likelihood test to test for association between rare variants and disease phenotypes. BMC Bioinformatics. 2013; 14:177.
27. Ionita-Laza I, Lee S, Makarov V, Buxbaum JD and Lin X. Sequence kernel association tests for the combined effect of rare and common variants. American journal of human genetics. 2013; 92(6):841-853.
28. Ward LD and Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic acids research. 2012; 40(Database issue):D930-934.